AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D

AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D

Submitted by admin on February 14, 2019 - 9:43am
Source: 
Endpoints
News Tags: 
AstraZeneca
MedImmune
R&D
restructring
Headline: 
AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D
snippet: 

MedImmune is history.

AstraZeneca execs acknowledged today that the company is sweeping the MedImmune brand name away as CEO Pascal Soriot streamlines the R&D organization, carving the group into 2 parts.

Do Not Allow Advertisers to Use My Personal information